£125.20

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£125 today · all-time low £121 (Aug 2026) · usually the usual

Springer Malignant Lymphomas & Hodgkin's Disease: Diagnosis Management

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 59 days · 59 data points (no recent data)

Historical
Generating forecast…
£125.51 £120.54 £121.62 £122.71 £123.79 £124.88 £125.96 23 August 2026 06 September 2026 21 September 2026 05 October 2026 20 October 2026
View at Amazon ↗

Price data last checked 32 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 59 days • 3 price levels

Days at Price
Current Price
18 days 30 days 11 days · current 0 8 15 23 30 £121 £124 £125 Days at Price

Price Analysis

Most common price: £124 (30 days, 50.8%)

Price range: £121 - £125

Price levels: 3 different prices over 59 days

Description

This comprehensive medical reference from Springer presents an authoritative collection of reviews on malignant lymphomas and Hodgkin's disease, addressing the rapidly evolving landscape of diagnosis, management, and clinical challenges. The volume explores fundamental mechanisms of lymphomagenesis alongside advances in morphologic classification essential for accurate disease identification. It covers emerging therapeutic agents, including both cytotoxic and biologic options, alongside innovative drug delivery strategies that reflect current clinical practice. Designed for healthcare professionals and internal medicine specialists, this text synthesises the latest developments in lymphoma treatment whilst addressing special clinical problems encountered in patient care. Volume 66 in the Cancer Treatment and Research series, it serves as an indispensable resource for practitioners seeking to stay current with rapidly advancing knowledge in haematologic malignancies and oncology management.

Key Features

Springer-published medical reference providing comprehensive reviews on malignant lymphomas and Hodgkin's disease diagnosis and treatment protocols.

Covers mechanisms of lymphomagenesis and advanced morphologic classification systems essential for accurate disease identification in clinical practice.

Explores cytotoxic agents, biologic therapies, and innovative drug delivery strategies reflecting contemporary lymphoma management approaches.

Volume 66 in the Cancer Treatment and Research series, offering specialist knowledge for internal medicine and oncology practitioners.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
99% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)

Springer

£127.75 30 Oct 2026
Aggressive Lymphomas (Hematologic Malignancies)
98% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.28 24 Sep 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
98% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 24 Sep 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
98% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 24 Sep 2026
Hodgkin's and Non-Hodgkin's Lymphoma: Cancer Treatment Research
98% match

Hodgkin's and Non-Hodgkin's Lymphoma: Cancer Treatment Research

Springer

£46.30 20 Oct 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
98% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.67 18 Sep 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
97% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£143.29 29 Oct 2026
Rare Lymphomas (Hematologic Malignancies)
97% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£107.55 29 Oct 2026
Wiley Skin Lymphoma: The Illustrated Guide - Medical Text
97% match

Wiley Skin Lymphoma: The Illustrated Guide - Medical Text

Wiley

£128.73 06 Nov 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£422.32 02 Nov 2026
Extranodal Lymphomas: Expert Consult - Online and Print
97% match

Extranodal Lymphomas: Expert Consult - Online and Print

Elsevier

£141.99 20 Oct 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
97% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£58.09 03 Oct 2026
Springer Malignant Lymphomas and Hodgkin's Disease Book
97% match

Springer Malignant Lymphomas and Hodgkin's Disease Book

Springer

£395.79 04 Nov 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
97% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£65.61 22 Sep 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
97% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£78.11 25 Sep 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
97% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£88.68 06 Oct 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£122.54 18 Sep 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£78.01 25 Sep 2026
Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)
97% match

Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)

Humana

£170.66 23 Oct 2026
Lymphoma: Methods and Protocols - Volume 971 Research Guide
97% match

Lymphoma: Methods and Protocols - Volume 971 Research Guide

Humana

£101.40 02 Oct 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
97% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£76.09 10 Oct 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
97% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£71.02 18 Sep 2026
T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)
97% match

T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)

Springer

£107.85 10 Oct 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£147.34 05 Nov 2026